A Patient Decision Aid for Anticoagulation Therapy in Patients With Nonvalvular Atrial Fibrillation: Development and Pilot Study
BackgroundAtrial fibrillation (AF) is one of the most common predisposing factors for ischemic stroke worldwide. Because of this, patients with AF are prescribed anticoagulant medications to decrease the risk. The availability of different options for oral anticoagulation mak...
Main Authors: | Kim Paul de Castro, Harold Henrison Chiu, Ronna Cheska De Leon-Yao, Lorraine Almelor-Sembrana, Antonio Miguel Dans |
---|---|
Format: | Article |
Language: | English |
Published: |
JMIR Publications
2021-08-01
|
Series: | JMIR Cardio |
Online Access: | https://cardio.jmir.org/2021/2/e23464 |
Similar Items
-
Effects of sufficient anticoagulation on ischemic stroke outcomes in patients with nonvalvular atrial fibrillation
by: Tae Jung Kim, et al.
Published: (2023-12-01) -
Prescribing Trends of Oral Anticoagulants in US Patients With Cirrhosis and Nonvalvular Atrial Fibrillation
by: Tracey G. Simon, et al.
Published: (2023-02-01) -
Nonvalvular atrial fibrillation in patients undergoing chronic hemodialysis. Should dialysis patients with atrial fibrillation receive oral anticoagulation?
by: Carmen Sánchez-González, et al.
Published: (2022-11-01) -
NOVEL ANTICOAGULANTS FOR THROMBOEMBOLIC COMPLICATIONS PREVENTION IN NONVALVULAR ATRIAL FIBRILLATION
by: D. A. Itkin, et al.
Published: (2015-02-01) -
Features of Modern Anticoagulant Therapy in Patients with Nonvalvular Atrial Fibrillation and Chronic Kidney Disease
by: I. S. Daabul, et al.
Published: (2016-11-01)